Skip Navigation
Menu
Editorials |15 December 1993

The Primary Prevention of Sudden Death in Patients with Coronary Artery Disease

Michael J. Domanski, MD; Alfred E. Buxton, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Copyright 2004 by the American College of Physicians
2004
  • National Heart, Lung, and Blood Institute, Bethesda, MD 20892. Temple University School of Medicine, Philadelphia, PA 19140. Requests for Reprints: Michael J. Domanski, MD, Clinical Trials Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892.
×
FULL TEXT
About 300 000 people suffer sudden cardiac arrest in the United States each year [1]. In those who recover, the risk for recurrent cardiac arrest approaches 30% during the next 2 years when the initial arrest was not associated with acute myocardial infarction [2, 3]. This risk has increased interest in secondary prevention, that is, in preventing subsequent cardiac arrest. Unfortunately, only a few persons who have an out-of-hospital cardiac arrest survive to hospital discharge [3, 4]. Focused attempts at resuscitation by community-based emergency teams result in survival rates of 14% to 16% of cardiac arrests [3, 4]. Because of the continuing dismal prognosis, the effect of secondary prevention, no matter how effective, is limited. Attention is now focused on primary prevention (preventing an initial episode of cardiac arrest). For this maneuver to substantially reduce mortality, however, those persons in the population who are at high risk for cardiac arrest must be identifiable, and effective interventions to prevent cardiac arrest must be available.
In this issue of Annals, Myerburg and colleagues [5] address the problem of identifying those persons in the total population who are at increased risk for cardiac arrest. Because the 300 000 deaths that occur each year in the United States occur in a population of more than 250 million, the incidence of cardiac arrest in the total population is low. Applying any active intervention to the entire population is impractical; therefore, those groups at high risk must be identified. In the article...
FULL TEXT
PDF
Not Available
Citations
Citation

Domanski MJ, Buxton AE. The Primary Prevention of Sudden Death in Patients with Coronary Artery Disease. Ann Intern Med. 1993;119:1218–1220. doi: 10.7326/0003-4819-119-12-199312150-00011

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1993;119(12):1218-1220.

DOI: 10.7326/0003-4819-119-12-199312150-00011

1 Citations

Related Articles
Comparing Impact and Cost-Effectiveness of Primary Prevention Strategies for Lipid-Lowering
Annals of Internal Medicine; 150 (4): 243-254
Implantable Cardioverter-Defibrillators for Primary Prevention in Patients With Ischemic or Nonischemic Cardiomyopathy: A Systematic Review and Meta-analysis
Annals of Internal Medicine; 167 (2): 103-111
Update in Cardiology
Annals of Internal Medicine; 152 (12): 786-791
Death and Cardiac Arrest in U.S. Triathlon Participants, 1985 to 2016: A Case Series
Annals of Internal Medicine; 167 (8): 529-535
View MoreView Less

Journal Club
Guideline: USPSTF recommends against menopausal estrogen for primary prevention of chronic conditions
Annals of Internal Medicine; 168 (6): JC26
Review: In primary prevention, BP-lowering treatment reduces major CV events in patients with SBP ≥ 140 mm Hg
Annals of Internal Medicine; 168 (4): JC15
Review: Aspirin for CVD primary prevention increases gastrointestinal bleeding and hemorrhagic stroke
Annals of Internal Medicine; 165 (4): JC17
In primary prevention, the ACC/AHA risk-based approach predicted ASCVD better than trial-based or hybrid approaches
Annals of Internal Medicine; 164 (8): JC47
View MoreView Less

Related Topics
Cardiology
Coronary Heart Disease
Emergency Medicine
Prevention/Screening
Rhythm Disorders and Devices

Cardiology, Coronary Heart Disease, Emergency Medicine, Prevention/Screening, Rhythm Disorders and Devices.

PubMed Articles
Pneumothorax-Time for New Guidelines?
Semin Respir Crit Care Med 2019;40(3):314-322.
Personalized Prediction of Cardiovascular Benefits and Bleeding Harms From Aspirin for Primary Prevention: A Benefit-Harm Analysis.
Ann Intern Med 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×